Showing results (111-120 of 467) with videos related to
Sort By:
Pageof 47
Journal of the American College of Cardiology|September 17, 2025
Is Type 2 Diabetes a Modifiable Risk Factor for the Evolution and Progression of Heart Failure With a Preserved Ejection Fraction?Milton Packer, Carolyn S P Lam, Javed Butler, et al.JACC. Cardiovascular Imaging|November 21, 2021
Subclinical Pulmonary Congestion and Abnormal Hemodynamics in Heart Failure With Preserved Ejection FractionC Charles Jain, Juerg Tschirren, Yogesh N V Reddy, et al.Journal of the American College of Cardiology|July 25, 2009
Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fractionBarry A Borlaug, Carolyn S P Lam, Véronique L Roger, et al.American Journal of Hypertension|April 5, 2015
Associations of Alterations in Pulsatile Arterial Load With Left Ventricular Longitudinal StrainZi Ye, Thais Coutinho, Patricia A Pellikka, et al.Journal of the American College of Cardiology|January 28, 2012
Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapyShmuel Schwartzenberg, Margaret M Redfield, Aaron M From, et al.Mayo Clinic Proceedings|August 11, 2023
Obesity, Cardiorenal Comorbidities, and Risk of Hospitalization in Patients With Heart Failure With Preserved Ejection FractionCamilla S Morgen, Christiane L Haase, Tugce K Oral, et al.Journal of Cardiovascular Translational Research|June 10, 2021
Cardiopulmonary Exercise Testing with Echocardiography to Identify Mechanisms of Unexplained DyspneaPieter Martens, Lieven Herbots, Philippe Timmermans, et al.European Journal of Heart Failure|November 1, 2014
Impact of chronic changes in arterial compliance and resistance on left ventricular ageing in humansPeter Wohlfahrt, Margaret M Redfield, Vojtech Melenovsky, et al.Journal of Cardiac Failure|July 9, 2025
Oral Levosimendan for the Treatment of Pulmonary Hypertension due to Heart Failure With Preserved Ejection Fraction: Rationale and Design of the LEVEL TrialHidenori Yaku, Daniel Burkhoff, Barry A Borlaug, et al.European Heart Journal|February 9, 2022
Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortalityFrederik H Verbrugge, Kazunori Omote, Yogesh N V Reddy, et al.Pageof 47